Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle

Journal of Thoracic and Cardiovascular Surgery

Volumn 118, Issue 2, 1999, Pages 339-347

  Poliakova, L ^a   Kovesdi, I ^a   Wang, X ^a   Capogrossi, M C ^a   Talan, M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; HEART FUNCTION; MEDIATOR RELEASE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; RABBIT; RAT; SKIN ULCER; VASCULAR ENDOTHELIUM;

EID: 0032813580     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70225-4     Document Type: Article

References (28)

1. C Bauters T Asahara LP Zheng T Takeshita S Bunting N Ferrara Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor Circulation 91 1995 2802 2809
2. JO Chleboun RN. Martins The development of the collateral circulation in an animal model of lower limb ischemia Aust N Z J Surg 64 1994 202 207
3. S Takeshita LQ Pu LA Stein AD Sniderman S Bunting N Ferrara Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia Circulation 90 Pt 2 1994 228 234
4. LQ Pu AD Sniderman R Brassard KJ Lachapelle AM Graham R Lisbona Enhanced revascularization of ischemic limb by angiogenic therapy Circulation 88 1993 208 215
5. CA Mack SR Patel EA Schwarz P Zanzonico RT Hahn A Ilercil Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart J Thorac Cardiovasc Surg 115 1998 168 176
6. JM Isner K Walsh J Symes A Pieczek S Takeshita J Lowry Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease Circulation 91 1995 2687 2692
7. JM Isner A Pieczek R Schainfeld R Blair L Haley T Asahara Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Lancet 348 1996 370 374
8. JM Isner K Walsh J Symes A Pieczek S Takeshita J Lowry Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease Hum Gene Ther 7 1996 959 988
9. RG Crystal Deficient adenovirus vector containing the VEGF121 cDNA to the ischemic myocardium of individuals with life-threatening diffuse coronary artery disease Clinical trial. Registration No. 9711-221 1998 The New York Hospital– Cornell Medical Center New York
10. JM. Isner Gene therapy for myocardial angiogenesis Clinical trial 1998 Tufts University School of Medicine Boston Registration No. 9802-088
11. T. McCluskey VEGF: preliminary clinical studies in patients with coronary artery disease Course angiogenesis & direct myocardial revascularization 1998 Jun 5-6 Washington Hospital Center; Washington [DC]
12. J. Symes VEGF: Status of clinical trail in peripheral vascular and myocardial disease Course angiogenesis & direct myocardial revascularization 1998 Jun 5-6 Washington Hospital Center; Washington [DC]
13. KH Plate PC. Warnke Vascular endothelial growth factor J Neur Oncol 35 1997 365 372
14. AT. Kenneth Vascular endothelial growth factor, a potent and selective angiogenic agent J Biol Chem 271 1996 603 606
15. SY Cheng M Nagane HJ Huang WK. Cavenee Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189 Proc Natl Acad Sci U S A 94 1997 12081 12087
16. MG Sirois ER. Edelman VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor Am J Physiol 272 1997 H2746 H2756
17. B Rizk M Aboulgar J Smitz R. Ron-El The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome Hum Reprod Update 3 1997 255 266
18. J Muhlhauser MJ Merrill R Pili H Maeda M Basic B Bewig VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo Circ Res 77 1995 1077 1086
19. UK Takeuchiy HV. Movat Simple method for quantitation of enhanced vascular permeability Proc Soc Exp Biol Med 133 1970 1384 1387
20. D Stephan EG. Nabel Gene and other biological therapies for vascular diseases Fundam Clin Pharmacol 11 1997 97 110
21. W. Casscels Growth factor therapies for vascular injury and ischemia Circulation 91 1995 2699 2702
22. O Hudlicka M Brown S. Egginton Angiogenesis in skeletal and cardiac muscle Physiol Rev 72 1992 369 396
23. M Jeltsch A Kaipainen V Joukov X Meng M Lasko H. Rauvala Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 276 1997 1423 1425
24. NF Liu QL. He The regulation effects of cytokines on lymphatic angiogenesis Lymphology 30 1997 3 12
25. RC Smith K. Walsh Prospects for intravascular Gene therapy J Clin Apheresis 12 1997 140 145
26. D. Connolly Vascular permeability factor a unique regulator of blood vessel function J Cell Biochem 47 1991 219 223
27. L Diaz-Flores R Gutierrez H. Varela Angiogenesis: an update Histol Histopathol 9 1994 807 843
28. JF Symes AD. Sniderman Angiogenesis: potential therapy for ischaemic disease [published erratum appears in Curr Opin Lipidol 1994;5(5):following table of contents] Cur Opin Lipidol 5 1994 305 312